TNF and rheumatoid arthritis: RTD-1 induced disease resolution more effectively than a TNFα inhibitor or MTX, and at rates exceeding that reported using a mouse anti-TNFα antibody [45], or the < 10% remission rate observed in treated RA patients [46].